Skip to main content
Data Highlights Editorials
All dashboards COVID Symptom Study Sweden (Partner) CRUSH Covid Uppsala (Partner) Multi-disease serology Post COVID-19 condition Register-based vaccination (RECOVAC) SARS-CoV-2 tests at National Pandemic Centre SARS-CoV-2 variant competition SARS-CoV-2 whole genome sequencing (Region Uppsala) Serology tests for SARS-CoV-2 at SciLifeLab Swedish COVID-19 publications over 5 years Vaccine administration: COVID-19 Wastewater: Enteric Virus Quantification (GU) Wastewater: Influenza Quantification (SLU) Wastewater: RSV Quantification (SLU) Wastewater: SARS-CoV-2 Quantification
Share data Available datasets Data dashboards Data sources & repositories Sample collection database Research data management
Funding opportunities Ongoing research projects Recent Swedish Publications Register-based research
Outbreaks SciLifeLab PLP PLP Capabilities
All topics Antibiotic resistance COVID-19 Enteric viruses Infectious diseases Influenza Mpox Respiratory Syncytial Virus (RSV)

Data highlights : Mpox

The Data Highlights section showcases recently published datasets relevant to pandemic preparedness research by researchers affiliated with a Swedish research institute. Specifically, in our case we write about e.g. COVID-19 and SARS-CoV-2, infectious diseases in general, and antibiotic resistance. The goal is to highlight openly shared data that can potentially be used by many other researchers to make further discoveries.

Topic: Mpox

January 8, 2026
Latest study on Mpox vaccination highlights the need for booster doses
A cohort study aimed to find insights into vaccine-induced immunity over time for mpox (clade 2b) infection. Neutralising antibodies declined noticeably by 9 months, highlighting the potential need for booster doses.
Mpox Infectious Diseases